INVA
Price
$18.86Alerts
Change
-$0.22 (-1.15%)
Updated
Nov 11 closing price
Capitalization
1.38B
112 days until earnings call
Intraday BUY SELL Signals
LGND
Price
$316.83Alerts
Change
+$2.67 (+0.85%)
Updated
Nov 11 closing price
Capitalization
6.1B
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INVA vs LGND

INVA vs LGND Comparison Chart in %
View a ticker or compare two or three
VS
INVA vs. LGND commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INVA is a Hold and LGND is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for INVA with price predictions
Nov 10, 2026

INVA in downward trend: price dove below 50-day moving average on November 05, 2026

INVA moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVA as a result. In 43 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for INVA turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 29 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

The 10-day moving average for INVA crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVA advanced for three days, in 186 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

INVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 120 of 204 cases where INVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. INVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.119) is normal, around the industry mean (3.498). P/E Ratio (3.709) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (3.173) is also within normal values, averaging (9.059). Dividend Yield (0.052) settles around the average of (130.981) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for LGND with price predictions
Nov 10, 2026

Aroon Indicator for LGND shows an upward move is likely

LGND's Aroon Indicator triggered a bullish signal on November 10, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 259 similar instances where the Aroon Indicator showed a similar pattern. In 214 of the 259 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on LGND as a result. In 70 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

Following a +2.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where LGND advanced for three days, in 258 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 57 cases where LGND's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for LGND turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 35 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

LGND broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. LGND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.309) is normal, around the industry mean (3.498). P/E Ratio (30.167) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (1.267) is also within normal values, averaging (9.059). Dividend Yield (0.006) settles around the average of (130.981) among similar stocks. P/S Ratio (20.325) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
INVA vs LGND: Fundamental Ratings
INVA
LGND
OUTLOOK RATING
1..100
5831
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
813
SMR RATING
1..100
2844
PRICE GROWTH RATING
1..100
7039
P/E GROWTH RATING
1..100
9695
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INVA's Valuation (83) in the Pharmaceuticals Other industry is in the same range as LGND (90) in the Biotechnology industry. This means that INVA’s stock grew similarly to LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (3) in the Biotechnology industry is significantly better than the same rating for INVA (81) in the Pharmaceuticals Other industry. This means that LGND’s stock grew significantly faster than INVA’s over the last 12 months.

INVA's SMR Rating (28) in the Pharmaceuticals Other industry is in the same range as LGND (44) in the Biotechnology industry. This means that INVA’s stock grew similarly to LGND’s over the last 12 months.

LGND's Price Growth Rating (39) in the Biotechnology industry is in the same range as INVA (70) in the Pharmaceuticals Other industry. This means that LGND’s stock grew similarly to INVA’s over the last 12 months.

LGND's P/E Growth Rating (95) in the Biotechnology industry is in the same range as INVA (96) in the Pharmaceuticals Other industry. This means that LGND’s stock grew similarly to INVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INVALGND
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
63%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 20 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
83%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (INVA: $19.08 vs. LGND: $314.16)
Brand notoriety: INVA and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INVA: 90% vs. LGND: 94%
Market capitalization -- INVA: $1.38B vs. LGND: $6.1B
INVA [@Biotechnology] is valued at $1.38B. LGND’s [@Biotechnology] market capitalization is $6.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INVA’s FA Score shows that 1 FA rating(s) are green while LGND’s FA Score has 1 green FA rating(s).

  • INVA’s FA Score: 1 green, 4 red.
  • LGND’s FA Score: 1 green, 4 red.
According to our system of comparison, LGND is a better buy in the long-term than INVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INVA’s TA Score shows that 5 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • INVA’s TA Score: 5 bullish, 5 bearish.
  • LGND’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, INVA is a better buy in the short-term than LGND.

Price Growth

INVA (@Biotechnology) experienced а -8.84% price change this week, while LGND (@Biotechnology) price change was +0.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.

Reported Earning Dates

INVA is expected to report earnings on Mar 03, 2027.

LGND is expected to report earnings on Mar 04, 2027.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with ARQT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then ARQT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
+0.42%
ARQT - INVA
38%
Loosely correlated
+4.52%
ARVN - INVA
35%
Loosely correlated
+2.37%
DTIL - INVA
34%
Loosely correlated
-1.86%
LGND - INVA
31%
Poorly correlated
+0.00%
ATRA - INVA
31%
Poorly correlated
-0.98%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SETH38.661.29
+3.44%
ProShares Short Ether ETF (SETH)
PJP130.540.86
+0.66%
Invesco Pharmaceuticals ETF (PJP)
CNAV36.310.01
+0.03%
Mohr Company Nav ETF (CNAV)
VCR403.06-0.31
-0.08%
Vanguard Consumer Discretionary ETF (VCR)
SPYT16.22-0.04
-0.25%
Defiance S&P 500 Target Income ETF (SPYT)